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Two new 20,24-bishomo-25-norscalaranes, compounds 1 and 2, and two new and two known 20,24-bishomoscalaranes,
compounds 3-6, have been isolated from the Indonesian marine sponge Carteriospongia foliascens. The structures of
1-6 were determined by spectroscopic analysis. Compounds 1 and 3-6 inhibit RCE-protease activity.
The Ras signaling pathway has been identified as an important
target for the development of anticancer drugs.1-3 Ras proteolysis
represents one promising target for disrupting Ras signaling. The
characterization of hRCE1 (human Ras-coverting enzyme),2 which
is responsible for proteolytic processing of Ras, led to the
development of an assay to screen for RCE-protease inhibitors.3
In 2002 we published the structures of the sesterterpene barangca-
doic acid A and the norsesterterpenes rhopaloic acids D to G. These
terpenoids, isolated from an Indonesian sponge, represented the first
reported natural product inhibitors of the RCE-protease.4 Sponges
continue to be the single richest marine source of structurally novel
secondary metabolites.5 Crude extracts of the Indonesian sponge
Carteriospongia foliascens (order Dictyoceratida, family Thorec-
tidae) showed promising activity in the RCE protease assay.
Sponges of the order Dictyoceratida and particularly the family
Thorectidae are known sources of scalarane-based sesterterpenes,
and many 20,24-bishomoscalarane and 20,24-bishomo-25-norsca-
larane derivatives have been isolated from members of the genus
Phyllospongia (syn. Carteriospongia).5,6 Bioassay-guided fraction-
ation of the extracts of C. foliascens led to the identification of the
two new bishomonorscalaranes 1 and 2 and two new and two
known bishomoscalaranes, 3-6. Details of the isolation, structure
elucidation, and biological activities of the terpenoids 1-6 are
presented below.
Results and Discussion
C. foliascens (order Dictyoceratida, family Thorectidae) was
harvested by hand using scuba on reefs off Palau Barang Lompo
near Makassar, Indonesia. Freshly collected sponge was repeatedly
extracted with EtOH. The EtOH extracts were combined, concen-
trated in Vacuo, and then partitioned between H2O and EtOAc.
Repeated fractionation of the EtOAc-soluble materials via Sephadex
LH-20 and flash silica gel column chromatography, followed by
repetitive reversed-phase HPLC, gave pure samples of the two new
20,24-bishomo-25-norscalaranes 1 and 2, inseparable mixtures of
the new epimeric 20,24-bishomoscalarane ketals 3 and 4, and the
recently reported epimeric 20,24-bishomoscalarane ketals 5 and 6.7
Compound 1 was obtained as a clear oil that gave a [M + Na]+
ion in the HRESIMS at m/z 539.3708, appropriate for a molecular
formula of C32H52O5, requiring seven sites of unsaturation. The 1H
NMR spectrum of 1 contained five methyl singlets (δ 0.78, 0.83,
0.86, 1.04, 2.24), two methyl doublets (δ 0.89 (J ) 6.8 Hz), 0.91
(J ) 6.7 Hz)), and one methyl triplet (δ 0.72 (J ) 7.4 Hz)). A
search of the literature using the MarineLit8 database with methyl
number criteria rapidly identified 20,24-bishomoscalaranes and
20,24-bishomo-25-norscalaranes as likely candidates for a carbon
skeleton template. The 1H/13C/COSY/HSQC/HMBC NMR data
obtained for 1 (Table 1) identified resonances that could be assigned
to 32 carbon atoms, which was consistent with the HRESIMS data.
In addition to the eight methyls, the presence of a conjugated
trisubstituted olefin (δ 138.1 (C-17); 6.58 s (H-18), 151.4 (C-18)),
a conjugated methyl ketone (δ 201.4 (C-24); 2.24 s (H-26), 25.3
(C-26)), two carbinol methines (δ 4.54 (H-16), 63.3 (C-16); 3.68
(H-3′), 73.1 (C-3′)), and an ester (δ 5.08 (H-12), 76.7 (C-12); 172.5
(C-1′)) was apparent in the NMR data and accounted for three of
the seven required sites of unsaturation. These structural features
and the chemical shifts of the remaining 13C resonances are
markedly similar to the structural components of phyllofenone C
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(7) isolated from the closely related Indonesian sponge Strepsi-
chordia aliena (family Thorectidae).9 The NMR assignments for
the sesterterpene portion of 1 were almost identical to those assigned
to 7, and COSY and HMBC NMR data showed that 1 contained a
3-hydroxy-4-methylpentanoate ester in place of the 3-acetoxybu-
tanoate ester found in 7. HMBC correlations were observed from
H-12 (δ 5.08) and both of the methylene H-2′ protons (δ 2.38 and
2.47) to the C-1′ ester carbonyl resonance at δ 172.5, demonstrating
that the pentanoate moiety was attached at C-12 of the sesterterpene
fragment of 1. Analysis of 2D NOESY and J coupling values
(Figure 1) demonstrated that the relative configuration of the
substituents on the sesterterpene core of 1 was the same as that
observed in 7.
Compound 2 gave a [M + Na]+ ion in the HRESIMS at m/z
525.3557, appropriate for a molecular formula of C31H50O5, which
differed from the molecular formula of 1 simply by the loss of
CH2. The 1H NMR spectrum of 2 was remarkably similar to that
of 1, the major difference being the absence of the two methyl
doublets assigned to the isopropyl group of the 3-hydroxy-4-
methylpentanoyl moiety in 1. Instead, the 1H NMR spectrum of 2
contained a new methyl triplet at δ 0.93 (J ) 7.4 Hz), and analysis
of the 2D NMR data (Table 1) demonstrated that the 3-hydroxy-
4-methylpentanoyl unit in 1 had been replaced by a 3-hydroxy-
pentanoyl moiety in 2. All other structural features of 1 and 2 were
identical.
Compounds 3 and 4 were isolated as an inseparable mixture of
C-24 epimers that gave a [M + Na]+ ion at m/z 611.3925 in the
HRESIMS appropriate for a molecular formula of C35H56O7. Two
sets of signals with partial overlap were observed in the 1H and
13C NMR of this mixture, and the 1H NMR integrals indicated that
the two compounds were present in a 4:1 ratio. Analysis of the
1H/13C/COSY/HSQC/HMBC NMR data (Tables 2 and 3, Figure
2) obtained for the mixture indicated that compounds 3 and 4 were
closely related to 1 and 2, with the same methyl substitution pattern
on the A, B, and C rings, a 3-hydroxy-4-methylpentanoyl moiety
at C-12, and an oxymethine at C-16 (δ 69.0 and 68.5). The presence
of additional structural components (chemical shifts quoted for the
major isomer 3) including a conjugated tetrasubstituted olefin (δ
156.8 (C-17), 137.6 (C-18)), an ester (δ 168.1 (C-25)), a ketal
carbon (δ 104.5 (C-24)), a carbinol methine (δ 3.68 (H-3′), 73.1
(C-3′)), a methyl singlet (δ 1.60 (H-26), 23.5 (C-26)), and an
oxyethyl group (δ 3.56/3.69 (dq, J ) 16.1, 7.1 Hz) (H′′-1), 65.5
(C-1′′); 1.23 (t, J ) 7.1 Hz) (H-2′′), 15.6 (C-2′′)) was also apparent
in the NMR data for 3 and 4. HMBC correlations observed between
C-18 (δ 137.6) and Me-23 (δ 1.15), H-16 (δ 4.08), and H-14 (δ
1.95) and between C-17 (δ 156.8) and both H-15eq (δ 2.03) and
H-16 (δ 4.08) indicated that an R,"-unsaturated-γ-lactone was fused
to ring D. In addition, a methyl substituent at the ketal carbon C-24
satisfied the observed HMBC correlations between Me-26 (δ 1.60)
and both C-17 (δ 156.8) and C-24 (δ 104.5). The butenolide
functionality in the position proposed for 3 and 4 is commonly
seen in the 20,24-bishomoscalaranes found in the Phyllosponginae
subfamily of sponges.10 HMBC cross-peaks observed between H-16
(δ 4.08) and C-1′′ (δ 65.5) and between H-1′′ (δ 3.56/3.69) and
C-16 (δ 69.0) demonstrated that the ethoxy fragment was attached
at C-16. The NMR data indicated clearly that compounds 3 and 4
are epimers at the ketal C-24. Analysis of 2D NOESY and J
coupling values demonstrated that the relative configuration of the
substituents on the sesterterpene portion of 3 and 4 was the same
as that observed in 1 and 2 (Figure 1). In the major isomer 3, a 2D
NOESY correlation between H-16 and Me-26 indicated that Me-
26 is in the "-configuration. The presence of a ethoxide functionality
at C-16 in 3 and 4 is unusual. The sponge tissue was worked up in
EtOH, so it is possible that compounds 3 and 4 are artifacts of the
isolation procedure.
Compounds 5 and 6 were also isolated as an inseparable mixture
that gave a [M + Na]+ ion in the HRESIMS at m/z 551.3351,
appropriate for a molecular formula of C32H48O6. The 1H NMR
indicated that the two compounds were in a 1:1 ratio and were
closely related to compounds 1-4. Analysis of the 1H/13C/COSY/
HSQC/HMBC NMR data (Tables 2 and 3) obtained for the mixture
indicated that the oxygen substituent at C-16 found in 1-4 was
replaced with a ∆15-16 double bond. Hence, 5 and 6 were found to
Table 1. NMR Data for Compounds 1 and 2 (600 MHz,
CDCl3)
1 2
atom #a δCb δH (J in Hz) δCb δH (J in Hz)
1ax 39.9 0.66, td (12.5, 3.4) 40.1 0.65, bt (12.2)
1eq 1.54, ndc 1.54, nd
2ax 18.1 1.47, nd 18.2 1.46, nd
2eq 1.35, m 1.34, m
3ax 36.4 0.83, nd 36.6 0.82, nd
3eq 1.64 63, nd
4 35.8 36.2
5 58.3 0.93, nd 58.5 0.93, nd
6 17.9 1.44, nd 17.9 1.44, nd
1.56, nd 1.56, nd
7ax 40.8 1.09, nd 41.1 1.09, nd
7eq 1.80, dm (12.6) 1.80, dm (12.9)
8 36.8 37.0
9 53.3 1.35, m 53.5 1.35, m
10 36.8 37.0
11 22.1 1.76, nd 22.3 1.76, nd
1.76, nd 1.76, nd
12 76.7 5.08, bs 76.7 5.08, bs
13 41.3 41.6
14 43.5 1.87, dm (11.2) 43.6 1.86, dm (12.2)
15 25.0 1.55-1.58, nd 25.1 1.58, nd
1.85, dm (10.8) 1.85, dm (14.2)
16 63.3 4.54, d (4.1) 63.2 4.54, d (4.1)
17 138.1 138.2
18 151.4 6.58, s 151.6 6.58, s
19 28.3 0.78, s 28.5 0.78, s
20 24.3 1.16, dq (14.4, 7.2) 24.5 1.16, dq (14.0, 7.0)
1.50, nd 1.51, nd
21 17.0 0.83, s 16.9 0.83, s
22 17.0 0.86, s 17.1 0.86, s
23 19.6 1.04, s 19.7 1.05, s
24 201.4 201.5
26 25.3 2.24, s 25.6 2.24, s
27 8.5 0.72, t (7.2) 8.7 0.72, t (6.8)
1′ 172.5 172.4
2′ 39.3 2.38, dd (15.7, 9.6) 41.8 2.38, dd (15.7, 9.2)
2.47, dd (15.7, 3.1) 2.49, dd (15.7, 3.4)
3′ 73.1 3.68, m 69.6 3.85, m
4′ 33.0 1.67, nd 29.6 1.49, nd
1.49, nd
5′ 17.4 0.91, d (6.7) 10.0 0.93, t (7.4)
6′ 18.4 0.89, d (6.8)
a Numbering system follows that proposed by Kazlauskas et al.6
b Values obtained from HSQC and HMBC correlations. c Multiplicity
not determined due to overlapping signals/chemical shifts determined
from 2D data.
Figure 1. Summary of the significant NOSEY correlations (dashed)
and J coupling values used to assign the relative stereochemistry
of compounds 1, 3, and 4.
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be the C-12 epimers of the known metabolites phyllactones D and
E, isolated from Phyllospongia foliascens.11 Compounds 5 and 6
have previously been isolated from the sponge Phyllospongia
papyracea collected in the South China Sea.7
Compound 1 and the mixtures of 3/4 and 5/6 all had IC50 values
of 4.2-38.0 µg/mL in the RCE-protease assay (Table 4), which
utilizes a fluorescent-labeled peptide from the carboxy terminal of
farnesylated K-Ras as substrate and is analyzed by reversed-phase
HPLC as described previously.3 Additionally, the compounds were
tested against four tumor cell lines for inhibition of cell growth.
The LoVo colon cell line has a mutated K-Ras and activated Ras
pathway, and consequently it is quite sensitive to Ras pathway
inhibitors. CACO-2 is a colon tumor cell line that has normal Ras
and is generally resistant to Ras pathway inhibitors. PC-3 is a
prostate tumor line and MDA-468 is a breast cancer cell line (both
with mutated PTEN and p53 but not RAS) that were not expected
to be particularly sensitive to Ras pathway inhibition. The
compounds do not appear to exhibit a significant trend of stronger
activity against the LoVo cell line compared to CACO-2 (or for
the other two cell lines), the expected trend for RCE-protease
inhibitors. The mixtures of 3/4 and 5/6 have similar activities in
both the cell-based assays and the enzyme assays, which might
suggest that the cytotoxic effect of these compounds results from
modulating a target outside of the Ras pathway. A compound that
inhibits only a RAS pathway target would be expected to be
selective for LoVo over CACO-2 and also would be expected to
inhibit cell growth at concentrations higher than that needed to
inhibit the enzyme target in Vitro. Furthermore compound 1 is even
more active in the cell-based assays than in the enzyme assay, which
suggests that the cytotoxic effect of 1 results from hitting more
than one molecular target or at least a different target than the others.
The assay results for the mixtures of 3/4 and 5/6 are further
complicated since the individual components may have different
physical properties (such as permeability and solubility at the µM
levels needed) and/or different target activities.
Experimental Section
General Experimental Procedures. Optical rotations were recorded
on a Jasco P1010 polarimeter, and UV spectra were recorded on a
Waters 2487 UV dectector. 1H and 13C NMR spectra were recorded
on a 600 MHz spectrometer with a 5 mm inverse probe or a 5 mm
inverse cryoprobe. 1H chemical shifts are referenced to the residual
CDCl3 signal (δ 7.24 ppm), and 13C chemical shifts are referenced to
the CDCl3 solvent peak (δ 77.0 ppm).
Sponge Material. Specimens of Carteriospongia foliascens (Pallas,
1766) were collected by hand using scuba at a depth of 10 m near
Palau Barang Lompo, Makassar, Sulawesi, Indonesia, in October 1997
(S 5°02.52′, E 119°19.48′). A voucher sample has been deposited at
the Zoological Museum of Amsterdam (ZMA POR. 19109).
Extraction of Carteriospongia foliascens and Isolation of Com-
pounds 1-6. Freshly collected sponge (110 g) was cut into small pieces
and immersed in and subsequently extracted repeatedly with EtOH (3
× 300 mL). The combined ethanolic extracts were concentrated in
Vacuo, and the resultant oil was shipped to Vancouver. The extract
was then partitioned between EtOAc (3 × 5 mL) and H2O (15 mL).
The combined EtOAc extract was evaporated to dryness, and the
resulting oil was chromatographed on Sephadex LH-20. First 4:1
MeOH/CH2Cl2 and second 20:5:2 EtOAc/MeOH/H2O was used as
eluent to give early eluting bioactive fractions from both columns, which
exhibited a multitude of 1H NMR signals between 3.5 and 6.7 ppm.
This material was further fractionated using silica gel flash chroma-
tography, employing a step gradient from 19:1 hexanes/EtOAc to
Table 2. 1H NMR Data for Compounds 3, 4, 5, and 6 (600 MHz, CDCl3)
atom #a 3 δH (J in Hz) 4 δH (J in Hz) 5 and 6 δH (J in Hz)
1ax 0.60, td (12.5, 3.6) 0.60, td (12.5, 3.6) 0.61, tm (12.4)
1eq 1.57, ndb 1.57, nd 1.58, nd
2ax 1.46, nd 1.46, nd 1.47, nd
2eq 1.33, dm (14.2) 1.33, dm (14.2) 1.34, nd
3ax 0.82, nd 0.82, nd 0.83, nd
3eq 1.66, nd 1.66, nd 1.62, nd
5 0.91, nd 0.91, nd 0.88, nd
6 1.48, nd 1.48, nd 1.47, nd
1.57, nd 1.57, nd 1.53, nd
7ax 0.98, td (12.5, 3.5) 0.98, td (12.5, 3.5) 1.00, nd
7eq 1.77, dm (12.5) 1.77, dm (12.5) 1.91 and 1.93, nd
9 1.24, m 1.24, nd 1.22, nd
11 1.69, nd 1.67, nd 1.63, nd
1.96, nd 2.01, nd 2.05, nd
12 5.66, bs 5.55, bs 5.51/5.56, bs
14 1.95, dm (13.2) 1.81, dm (13.6) 2.63/2.67, bs
15 1.44, tm (13.2) 1.47, nd 6.39/6.40, dd (9.6/9.8, 2.7/2.8)
2.03, nd J ) 13.2 Hz 2.03, nd
16 4.08, d (4.0) 4.16, d (4.0) 6.24/6.28, dd (9.6/9.8, 2.7/2.8)
19 0.81, s 0.77, s 0.78/0.79, s
20 1.16, nd 1.16, nd 1.15, nd
1.52, nd 1.52, nd 1.50, nd
21 0.83, s 0.82, s 0.83, s
22 0.89, s 0.89, s 1.01, s
23 1.15, s 1.13, s 1.04/1.06, s
26 1.60, s 1.69, s 1.62/1.65, s
27 0.73, t (7.4) 0.72, nd 0.73, t (7.4)
2′ 2.37, dd (16.1, 9.9) 2.32, nd 2.32-2.57, nd
2.45, dd (16.1, 2.3) 2.45, nd
3′ 3.74, m 3.64, m 3.86/3.90, m
4′ 1.64, nd 1.66, nd 1.49, nd
1.49, nd
5′ 0.90, d (6.8) 0.90, nd 0.94, t (7.4)
6′ 0.89, nd 0.89, nd
1″ 3.56, m 3.48, m
3.69 m 3.70, nd
2″ 1.23, t (7.1) 1.24, t (7.1)
a Numbering system follows that proposed by Kazlauskas et al.6 b Multiplicity not determined due to overlapping signals/chemical shifts determined
from 2D data.
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EtOAc. A RCE-protease inhibitory fraction, eluting with 19:1-3:1
hexanes/EtOAc, exhibited interesting 1H NMR signals. Mixtures of
compounds 1-6 were obtained from this fraction via C18 reversed-
phase HPLC using a CSC-Inertsil 150A/ODS2, 5 µm 25 × 0.94 cm
column, with 17:3 MeCN/H2O as eluent. From these mixtures after
fractionation with a second C18 reversed-phase HPLC, using the same
column but with 9:1 MeOH/H2O as eluent, compounds 1 (0.3 mg), 2
(0.1 mg), a mixture of 3 and 4 (0.8 mg), and a mixture of 5 and 6 (0.3
mg) were obtained all as clear oils.
Compound 1: clear oil; [R]25D 0.0 (c 0.20, CH2Cl2); UV (MeOH)
λmax (log ε) 232 (3.3) nm; 1H NMR, see Table 1; 13C NMR, see Table
1; (+)-HRESIMS [M + Na] m/z 539.3708 (calcd for C32H52O5Na,
539.3712).
Compound 2: clear oil; [R]25D 0.0 (c 0.13, CH2Cl2); UV (MeOH)
λmax (log ε) 229 (3.3) nm; 1H NMR, see Table 1; 13C NMR, see Table
1; (+)-HRESIMS [M + Na]+ m/z 525.3557 (calcd for C31H50O5Na,
525.3556).
Compounds 3 and 4: clear oil; [R]25D +26.0 (c 0.53, CH2Cl2); UV
(MeOH) λmax 204 nm; 1H NMR, see Table 2; 13C NMR, see Table 3;
(+)-HRESIMS [M + Na]+ m/z 611.3925 (calcd for C35H56O7Na,
611.3924).
Compounds 5 and 6: clear oil; [R]25D +30.0 (c 0.20, CH2Cl2); UV
(MeOH) λmax (log ε) 202 (3.76), 290 (3.77) nm; 1H NMR, see Table
2; 13C NMR, see Table 3; (+)-HRESIMS [M + Na]+ m/z 551.3351
(calcd for C32H48O6Na, 551.3349).
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Table 3. 13C NMR Data for Compounds 3, 4, 5, and 6 (150
MHz, CDCl3)
atom #a 3b 4b 5 and 6c
1 40.1 40.1 40.0
2 18.2 18.2 18.2
3 36.6 36.6 36.6
4 36.1 36.1 36.1
5 58.7 58.5 58.6
6 17.9 17.9 17.8
7 41.5 41.3 41.0
8 37.1 36.9d 37.2
9 53.7 53.1 52.5
10 37.1 37.0d 36.8
11 21.3 21.0 21.3
12 74.2 74.3 73.1
13 39.5 39.0 40.0
14 45.1 45.8 53.9
15 22.9 22.9 138.8
16 69.0 68.5 118.1
17 156.7 158.1 156.4/157.2
18 137.6 137.6 131.1
19 28.5 28.5 28.5
20 24.5 24.5 24.5
21 16.8 16.7 16.7
22 17.5 17.5 18.9
23 18.7 18.6 17.0
24 104.5 104.5 103.2
25 168.1 168.1 unassigned
26 23.5 25.8 23.4/24.5
27 8.6 8.6 8.64
1′ 170.1 171.8 171.1/171.3
2′ 40.1 39.0 41.8
3′ 73.2 72.8 69.7
4′ 33.2 33.2 29.5




a Numbering system follows that proposed by Kazlauskas et al.6
b Values obtained from 13C NMR spectrum. c Values obtained from
HSQC and HMBC correlations. d Assignments within a column are
interchangeable.
Figure 2. Summary of the significant COSY (bold bonds) and
HMBC (arrow) correlations used to assign the structure of
compounds 3 and 4.
Table 4. Inhibition of Both RCE-Protease and Cell
Proliferationa of Four Tumor Cell Lines
cell line assays IC50 (µg/mL)
compound
enzyme (RCE) assay
IC50 (µg/mL) PC3 LoVo CACO-2 MDA468
1 38 3.8 7.6 3.4 9.5
2 >100 >10 >10 >10 >10
3/4 4.2 3.2 2.9 4.2 4.4
5/6 9.0 3.7 3.4 6.2 >10
a Three-day treatment.
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